SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 102,400
+3,200 (3.23%)
At close: May 14, 2026
11.30% (1Y)
| Market Cap | 7.77T -4.0% |
| Revenue (ttm) | 706.74B +29.1% |
| Net Income | 266.95B +10.9% |
| EPS | 3,408.75 +10.9% |
| Shares Out | 78.31M |
| PE Ratio | 29.10 |
| Forward PE | 26.03 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 248,891 |
| Average Volume | 212,082 |
| Open | 99,300 |
| Previous Close | 99,200 |
| Day's Range | 98,800 - 102,400 |
| 52-Week Range | 87,900 - 144,100 |
| Beta | 0.79 |
| RSI | 53.33 |
| Earnings Date | May 7, 2026 |